This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
"These results illustrate that cannabis regulation, coupled with consumer education, can provide sufficient safeguards to protect -- and potentially even improve -- mental health outcomes, particularly among more vulnerable populations."
This election year, Capitol Hill buzzed with discussions about cannabis scheduling, hemp regulations, and the FDA’s evolving role in regulating cannabinoids. Yet, missing from these debates was one critical topic: the future of medical cannabis and protections for patients.
"The results of this study indicate that cannabis may be a relatively safe and effective treatment for chronic pain, sleep disturbances, and other conditions associated with aging, leading to subsequent reductions in prescription drug use and healthcare costs, as well as significant improvements in quality of life.
"The current findings suggest [that] cannabis-based medicinal products may be effective in reducing suicidal ideation, as well as other facets of health and well-being." The post Study: Patients Less Likely to Have Suicidal Thoughts Following Medical Cannabis Use appeared first on NORML.
Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.
5 things Everyone Should Know About Cannabis Rescheduling: 1. CANNABIS RESCHEDULING IS A VICTORY FOR PATIENTS BY PATIENTSCannabis is being rescheduled because of its “currently accepted medical use in treatment in the United States.”
The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine. ’
“Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”.
Are you allowed to travel with medical cannabis? Can you cross state lines with medical cannabis? Can you bring cannabis on a plane or train? These are just a few of the many questions that medical cannabispatients may have while travelling for the holidays. What about a bus?
Cannabis was listed as a Schedule I substance, a category for “drugs with no currently accepted medical use and a high potential for abuse”; this is a stricter classification than even raw opium, which is Schedule II. Now, two-thirds of Americans live in states where medical cannabis is legal.
"Just as patients taking traditional medications do not face punishment in the workplace unless their on-the-job performance is impaired, those who use medical cannabis during their off-hours should not face sanctions solely because of their status as a medical marijuana patient."
John Bel Edwards has signed a series of bills into law greatly expanding patients ability to access medical cannabis products. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer.
In the wake of the election many patients have questions about the priorities of the incoming Congress. million cannabispatients across the country are stuck under conflicting federal and state cannabis policy, with veterans comprising the largest contingent of them.
The Division of Cannabis Regulation today sent out emails to those in the Medical CannabisPatient Program and Opioid Alternative Patient Program stating that it was pleased to announce that a new online registration portal will be live on Tuesday, April 29, 2025. To find cannabis-friendly events in Illinois, visit here.
The post Study: Cannabis Use Associated With Improved Symptoms, Better Sleep in Patients Suffering From Post-Traumatic Stress appeared first on NORML. Moreover, they reported reductions in negative affect and improvements in overall well-being.
Additionally, a modification to the medical cannabis amendment we passed in 2014 opens the door for federal interference in state medical cannabis programs again (Section 531(b)) with double penalties. CLICK HERE to send a letter to your representatives telling them to prioritize patients!
In the wake of the election many patients have questions about the priorities of the incoming Congress. million cannabispatients across the country are stuck under conflicting federal and state cannabis policy, with veterans comprising the largest contingent of them.
One of those gaps is medical cannabis, which, in my opinion, is a tremendously underutilized tool. Even among the sickest and most vulnerable patients I see, I often find myself wondering: Could medical cannabis help this person?
Join Americans for Safe Access (ASA) for a Roundtable discussion on cannabis product recalls with key stakeholders to discuss the basics of recalls, how they work, what they mean for patients and consumer health, and why they signal a functioning cannabis regulatory system.
Over 54,000 Connecticut residents are currently registered to possess and and access medical cannabis. The post Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week appeared first on NORML.
We're excited to say the the October/November issue of CannabisPatient Care Magazine is now available online. I got her thoughts on how patients can talk to their doctor or oncologist about medical cannabis. It was great to hear her perspective, as a doctor, on an issue that we talk a lot about from the patient side.
Prior to the election, there were 19 states that allowed both recreational adult use and medical cannabis, 29 allowing medical cannabis only, and 2 states with a total prohibition on cannabis. Each of the states already have an established medical cannabis law so the ballot questions were largely focused on recreational use.
Under the law, which took effect upon signing, qualified patients may now legally possess up to a 90-day supply of cannabis at one time. Patients also now have the ability to consult with authorizing physicians via video conferencing and may obtain cannabis from dispensaries via curbside pick-up.
“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. The post Study: Cannabis Mitigates Symptoms in Patients with Treatment-Resistant Fibromyalgia appeared first on NORML.
Gavin Newsom that seek to expand the rights of cannabis consumers. The post California: Bills Expanding Marijuana Rights for Patients, Employees Advanced to Governor’s Desk appeared first on NORML. Lawmakers have advanced two bills to the desk of Democratic Gov.
"We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients.". The post Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia appeared first on NORML.
Under the plan, patients in the state’s medical access program will be able to purchase marijuana-infused gummies or other similar chewable products beginning on August 1, 2020. The post Minnesota: Regulators Okay Patients’ Access to Cannabis-Infused Edible Products appeared first on NORML.
Under the expanded law, employers may not discriminate against authorized patients of medical cannabis in the recruitment, hiring, designation, or termination process or when imposing disciplinary actions. The post Puerto Rico: Law Signed Protecting Medical CannabisPatients from Employment Discrimination appeared first on NORML.
A common challenge patients often experience when adult-use laws are adopted in their state is that legislative and regulatory improvements to medical cannabis programs are suspended while states pivot to organize adult-use models.
By Nikki Lawley & Oleg Maryasis, MS Medical cannabispatients in New York face unnecessary financial and accessibility barriers that limit their ability to receive the care they need.
Last week, Kentucky Governor Beshear signed Senate Bill 47 , that will eventually create medical cannabis access for some KY residents. Which unfortunately, means patients will continue to suffer in the meantime. Here is what you need to know about the new law…
For over two decades, I have been privileged to be a part of the medical cannabis movement as an advocate for patients in need, and member of Americans for Safe Access.
Nearly two decades ago, we founded Americans for Safe Access (ASA) to bring patients needs and voices out of the shadows and into the center of the national cannabis debate. Back then, patients were criminalized, stigmatized, and rarely heardtrotted out in courtrooms or used as talking points, then shut out of actual policy decisions.
“This study demonstrates that treatment with THC-rich cannabis in patients with mild to moderate UC is associated with clinical improvement.". The post Clinical Trial: Cannabis Inhalation Associated with Clinical in Patients with Ulcerative Colitis appeared first on NORML.
The post Delaware: Cannabis Activists Take on Corporate Marijuana, Patients Stage Boycott appeared first on NORML. Locals in Delaware are tangling with corporate, multi-state medical marijuana permit holders to pass a bill for full legalization.
Patient access and rights must take precedence over expediency.” The post Kentucky: Governor Signs Legislation Expediting Medical Cannabis Licensing, But Also Adding New Restrictions Upon Patients’ Access appeared first on NORML.
Americans for Safe Access (ASA) has been at the forefront of fighting for patients’ rights to access medical cannabis across four presidencies since our founding in 2002. We've crafted briefing materials and “100-day campaigns” for three incoming administrations on medical cannabis policy.
“These findings contribute robust evidence for clinicians regarding the potential benefits of medical cannabis in reducing the opioid burden for patients receiving long-term opioid therapy and possibly reduc[ing] their risk for overdose.”
South Dakota voters overwhelmingly approved a ballot measure legalizing medical cannabis access in 2020. The post South Dakota: Lawmakers Reject Bill that Sought to Limit Patients’ Medical Cannabis Access appeared first on NORML.
The South Dakota Department of Public Safety issued guidelines today for law enforcement requiring them to cease arresting those persons who identify as patients and meet certain qualifications. The post South Dakota: Protections for Medical CannabisPatients Take Effect Today appeared first on NORML.
NORML has long opined that patients must have access to cannabis flowers, stating: "Orally administered non-herbal forms of cannabis possess delayed onset and their effects are far less predictable than those of herbal cannabis.
Employment protections for medical cannabispatients in New Jersey could soon be strengthened following an important win for the plaintiff in an employment discrimination lawsuit filed against Amazon last year -- D.J.C. Amazon Com DEDC, LLC, et al.
On February 2, 2022, Governor Tate Reeves chose to sign SB 2095 into law, making Mississippi the 37th state to adopt medical cannabis laws. The adoption of these laws is the conclusion of a year-long struggle for the future of cannabis in Mississippi. . ASA strongly opposes both of these provisions.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content